Whats Next in the Research Multiple Phase 2 and Phase 3 clinical trials are exploring the role of GLP-1s in alcohol use disorder, substance use disorders, and binge-type eating behaviors
NAD+ may be prescribed to help improve certain conditions such as depression, anxiety, PTSD, and other symptoms related to inflammation or cognitive decline
Physiological Relevance: Its still debated whether GLP-3 has significant independent biological activity or if its primarily a byproduct of proglucagon processing
Endogenous GLP-1 is rapidly degraded primarily by dipeptidyl peptidase-4 (DPP-4), as well as neutral endopeptidase 24 } : CS1 maint: DOI inactive as of July 2026 (link) Journal of Diabetes
10.2165/11206370-000000000-00000 65 KinzigK
IGF1 potentiates the pro-inflammatory response in human peripheral blood mononuclear cells via MAPK